Category Archives: Podcasts – Insights

Running Through Walls: Thinking Long Term is the Greatest Gift

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to a value-based care incentive structure, and why building a valuable solution requires a long time horizon.

  • Subscribe:

Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management

Running Through Walls: Diversifying the Cap Table

Venrock partners Bryan Roberts and Bob Kocher, speak with Heather Fernandez, co-founder and CEO of Solv, about Solv’s mission, building more cap table diversity in tech, and the healthcare field today. Fernandez delves into Solv’s Series C funding round where she created a special purpose vehicle (SPV) focused on women of color, bringing in first-time investors who wouldn’t otherwise have access. Fernandez also shares how Solv is unlocking capacity with software, its pricing strategy, and its goals for the next 2-3 years.

  • Subscribe:

Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management

Running Through Walls: The Balancing Act of Drug Discovery

Larry Hamann, co-founder, president, and CEO of Interdict Bio, speaks with Venrock Vice President Mariana Mihalusova about lessons learned from his career in drug discovery. Hamann delves into where his love for organic chemistry stems from and why inclusive environments are essential to building successful teams. He also speaks about the do’s and don’ts when structuring collaborations with big pharma, when a drug is “good enough” to move forward in development and new approaches he’s excited for.

  • Subscribe:

Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management

Running Through Walls: Bust The Liars Without Elevating The Liars

Venrock partner Bob Kocher speaks with Dr. Drew Altman, CEO of the Henry J. Kaiser Family Foundation (KFF) and founding publisher of Kaiser Health News (KNH), about dealing with misinformation and skepticism with expertise and facts. Altman reveals how misinformation, fragmented media, and a broken political system exacerbate the public’s low trust in experts. Altman discusses KHN’s origin story, the importance of busting liars without elevating them, and his thoughts on the Inflation Reduction Act. 

  • Subscribe:

Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management

Running Through Walls: Healthy Skepticism in Product Management

Jim Del Favero, Head of Product at Figure, a fintech company using blockchain to help homeowners better tap their home equity, joins Venrock partner Brian Ascher to discuss what makes a great product manager. Del Favero reveals why great PMs focus on outcomes, not outputs, and critically think about the problem that needs to be solved. Del Favero and Ascher also talk through common mistakes PMs make, the engineering and PM relationship, and data-driven vs. years of experience decisions.

  • Subscribe:

Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management

Running Through Walls: Culture and Connection

Venrock partner Brian Ascher speaks with Nicole Alvino, co-founder and CEO of Firstup, about effective workforce communication both digitally and in person. Alvino highlights fostering employee connection through authentic and transparent communication, using the power of video to drive engagement, and discusses expectations for corporate social responsibility. Plus, Alvino reveals a non-obvious lesson learned – employees want to hear from their peers (not just their leaders).

  • Subscribe:

Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management

Running Through Walls: High Will Over High Skill 

Company success is predicated on the people, according to Daversa Partners founder and CEO, Paul Daversa. Venrock partner Bryan Roberts chats with Daversa about the nuances of recruiting impactful senior-level leadership candidates who are a fit for the needs of the company. They cover hiring high will over high skill, understanding that candidates are stage sensitive and ways to avoid terminal hires. Daversa also discusses the intentionality of Dreamscape, the challenges, and the impact they’ve made thus far.

  • Subscribe:

Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management

Running Through Walls: Course Correcting for Long-Term Success

Venrock partner Andrew Gottesdiener speaks with Jigar Raythatha, former CEO of Constellation Pharmaceuticals, about lessons learned from his time at Constellation. As Constellation has evolved from an early-stage company to being acquired by MorphoSys, Raythatha dives into its many life-cycles, his heavy involvement in the recruitment process, and the decision to conduct a PIPE financing. Raythatha also shares the characteristics to look for in an investor syndicate and the challenges of scaling a public company.

  • Subscribe:

Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management

Running Through Walls: Be Comfortable Being Uncomfortable

Venrock partner Racquel Bracken speaks with Markus Renschler, President and CEO of Cyteir Therapeutics, to discuss the journey that led him to Cyteir, and the company’s path to going public. Renschler dives into an important lesson his parents instilled in him from a young age, “be comfortable with being uncomfortable,” and explains how this lesson has played an important role in his career journey. As a practicing hematologist oncologist, Renschler highlights the value of people skills and how developing those skills can positively influence leadership style, recruiting, and even fundraising. Renschler shares some of his highs and lows along the drug development process, provides advice for young clinicians entering the industry, and how his experience as a practicing physician influences the decisions he makes as a CEO. 

  • Subscribe:

Want more? Here’s the latest on Running Through Walls.

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management

Running Through Walls: Public Health & Pandemic Premonitions

With rising reports of Omicron in the United States, Venrock partner Bryan Roberts speaks with Dr. Charity Dean, CEO and co-founder of Public Health Company (PHC), to discuss her predictions and concerns for the latest Covid-19 variant. Dean and Roberts also talk about the long-term societal impacts of Covid, the severity of disease, and which groups are best protected. As Covid-19 revealed the cracks in the U.S. public health system, Dean shares how she anticipates public infrastructure to evolve, including more public and private sector partnerships. Dean delves into what led her to become a public health officer, the most exciting part of her first year as CEO at PHC, and her thoughts on her starring role in Michael Lewis’s book The Premonition: A Pandemic Story. 

  • Subscribe:

Want more? Here’s the latest on Running Through Walls

Farzad Mostashari, founder and CEO of Aledade, speaks with Venrock’s Bryan Roberts and Bob Kocher about improving the quality and efficiency of patient care with a focus on preventative care. With the recent launch of Aledade Care Solutions and new focus on Medicare Advantage, Mostashari delves into Aledade’s efforts to scale and deliver where average primary care practices can’t. Mostashari also reveals his approach to value based care incentive structure, and why building a valuable solution requires a long time horizon.
  1. Thinking Long Term is the Greatest Gift
  2. Diversifying the Cap Table
  3. The Balancing Act of Drug Discovery
  4. Bust the Liars Without Elevating the Liars
  5. Healthy Skepticism in Product Management